Lei He

Title: Innovations by Lei He in Pharmaceutical Development

Introduction

Lei He is a notable inventor based in Jiangsu, China, recognized for his contributions to the pharmaceutical industry. He has been instrumental in developing innovative methods and formulations that enhance the quality and efficacy of medications.

Latest Patents

Lei He holds two significant patents that focus on dapagliflozin, a medication used to treat type II diabetes. The first patent, titled "Crystal form of dapagliflozin intermediate and preparation method therefor," discloses a highly purified crystal form of a dapagliflozin intermediate. This method allows for a sample purity of 99.3% or more, which is crucial for improving the overall quality of dapagliflozin. The preparation process is noted for its simplicity and suitability for industrial production. The second patent, "Dapagliflozin crystal form and preparation method and use thereof," introduces a new crystal form of dapagliflozin and outlines its preparation method. This patent also details the use of the crystal form in pharmaceutical compositions for treating type II diabetes.

Career Highlights

Lei He is currently associated with Jiangsu Hansoh Pharmaceutical Group Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has significantly impacted the development of diabetes treatments, showcasing his expertise and commitment to improving patient outcomes.

Collaborations

Lei He collaborates with talented individuals in his field, including Xiang Li and Jun Yu, who contribute to his research and development efforts.

Conclusion

Lei He's innovative work in the pharmaceutical sector, particularly in the development of dapagliflozin, highlights his role as a key inventor in enhancing medication quality and efficacy. His contributions are vital for advancing diabetes treatment options.